National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

microtubulin inhibitor EPC2407
A small molecule tubulin polymerization inhibitor with potential antineoplastic activity. Microtubulin inhibitor EPC2407 binds to the colchicine-binding site on beta-tubulin and inhibits the polymerization of tubulin into microtubules, which may result in cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. As a vascular disruption agent (VDA), this agent also disrupts tumor neovascularization, which may result in a reduction in tumor blood flow and tumor hypoxia and ischemic necrosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:EPC2407



Previous:Mevacor, Mexate, Mexate-AQ, MG 98, micronutrient-fortified probiotic yogurt
Next:midazolam hydrochloride, midostaurin, Mifeprex, mifepristone, Milestrol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov